Correction to: microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.

Wei-Luo Cai,Wen-Ding Huang,Bo Li,Tian-Rui Chen,Zhen-Xi Li,Cheng-Long Zhao,Heng-Yu Li,Yan-Mei Wu,Wang-Jun Yan,Jian-Ru Xiao

DOI: https://doi.org/10.1186/s12943-020-01226-1

IF: 37.3

2020-01-01

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

What problem does this paper attempt to address?

Microrna-124 Inhibits Bone Metastasis Of Breast Cancer By Repressing Interleukin-11 (Vol 17, 9, 2018)

Wei-Luo Cai,Wen-Ding Huang,Bo Li,Tian-Rui Chen,Zhen-Xi Li,Cheng-Long Zhao,Heng-Yu Li,Yan-Mei Wu,Wang-Jun Yan,Jian-Ru Xiao

DOI: https://doi.org/10.1186/s12943-020-01226-1

IF: 37.3

2020-01-01

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.
microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11

Wei-Luo Cai,Wen-Ding Huang,Bo Li,Tian-Rui Chen,Zhen-Xi Li,Cheng-Long Zhao,Heng-Yu Li,Yan-Mei Wu,Wang-Jun Yan,Jian-Ru Xiao

DOI: https://doi.org/10.1186/s12943-017-0746-0

IF: 37.3

2018-01-01

Molecular Cancer

Abstract:Background Most patients with breast cancer in advanced stages of the disease suffer from bone metastases which lead to fractures and nerve compression syndromes. microRNA dysregulation is an important event in the metastases of breast cancer to bone. microRNA-124 (miR-124) has been proved to inhibit cancer progression, whereas its effect on bone metastases of breast cancer has not been reported. Therefore, this study aimed to investigate the role and underlying mechanism of miR-124 in bone metastases of breast cancer. Methods In situ hybridization (ISH) was used to detect the expression of miR-124 in breast cancer tissues and bone metastatic tissues. Ventricle injection model was constructed to explore the effect of miR-124 on bone metastasis in vivo. The function of cancer cell derived miR-124 in the differentiation of osteoclast progenitor cells was verified in vitro. Dual-luciferase reporter assay was conducted to confirm Interleukin-11 (IL-11) as a miR-124 target. The involvement of miR-124/IL-11 in the prognosis of breast cancer patients with bone metastasis was determined by Kaplan-Meier analysis. Results Herein, we found that miR-124 was significantly reduced in metastatic bone tissues from breast cancers. Down-regulation of miR-124 was associated with aggressive clinical characteristics and shorter bone metastasis-free survival and overall survival. Restoration of miR-124 suppressed, while inhibition of miR-124 promoted the bone metastasis of breast cancer cells in vivo. At the cellular level, gain of function and loss-of function assays indicated that cancer cell-derived miR-124 inhibited the survival and differentiation of osteoclast progenitor cells. At the molecular level, we demonstrated that IL-11 partially mediated osteoclastogenesis suppression by miR-124 using in vitro and in vivo assays. Furthermore, IL-11 levels were inversely correlated with miR-124, and up-regulation IL-11 in bone metastases was associated with a poor prognosis. Conclusions Thus, the identification of a dysregulated miR-124/IL-11 axis helps elucidate mechanisms of breast cancer metastases to bone, uncovers new prognostic markers, and facilitates the development of novel therapeutic targets to treat and even prevent bone metastases of breast cancer.
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu,Mengxia Yu,Yanling Ren,Kongfei Li,Dominic M. Maggio,Chen Mei,Li Ye,Juying Wei,Jie Jin,Zhengping Zhuang,Hongyan Tong

DOI: https://doi.org/10.1038/s41598-017-14858-z

IF: 4.6

2017-01-01

Scientific Reports

Abstract:correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Correction to: Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway

Xiao-xiao Zuo,Ya Yang,Yue Zhang,Zhi-gang Zhang,Xiao-fei Wang,Yong-gang Shi

DOI: https://doi.org/10.1186/s12964-020-00641-7

IF: 7.525

2020-08-13

Cell Communication and Signaling

Abstract:An amendment to this paper has been published and can be accessed via the original article.

cell biology
Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17

Kai Han,Feng-Wei Wang,Chen-Hui Cao,Han Ling,Jie-Wei Chen,Ri-Xin Chen,Zi-Hao Feng,Jie Luo,Xiao-Han Jin,Jin-Ling Duan,Shu-Man Li,Ning-Fang Ma,Jing-Ping Yun,Xin-Yuan Guan,Zhi-Zhong Pan,Ping Lan,Rui-Hua Xu,Dan Xie

DOI: https://doi.org/10.1186/s12943-021-01350-6

IF: 37.3

2021-03-31

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

Zhi Xin,Cui Jin,Liu Chao,Zhang Zheng,Cao Liehu,Pan Panpan,Weng Weizong,Zhai Xiao,Zhao Qingjie,Hu Honggang,Qin Longjuan,Chen Xiao,Su Jiacan

DOI: https://doi.org/10.3389/fphar.2021.605592

IF: 5.6

2021-03-29

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2018.00022.].

pharmacology & pharmacy
Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2

Zhenming Jiang,Yuxi Zhang,Xi Chen,Pingeng Wu,Dong Chen

DOI: https://doi.org/10.1186/s12935-021-01945-5

IF: 6.429

2021-04-26

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Kun Qiao,Shipeng Ning,Lin Wan,Hao Wu,Qin Wang,Xingda Zhang,Shouping Xu,Da Pang

DOI: https://doi.org/10.1186/s13046-020-01645-4

2020-08-11

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction: circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer

Yiran Liang,Xiaojin Song,Yaming Li,Peng Su,Dianwen Han,Tingting Ma,Renbo Guo,Bing Chen,Wenjing Zhao,Yuting Sang,Ning Zhang,Xiaoyan Li,Hanwen Zhang,Ying Liu,Yi Duan,Lijuan Wang,Qifeng Yang

DOI: https://doi.org/10.1038/s41388-021-01750-4

IF: 8.756

2021-03-25

Oncogene

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41388-021-01750-4

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis: Erratum

Xian Li,Shuihua Lin,Zhifeng Mo,Jinxing Jiang,Haifeng Tang,Cailin Wu,Jian Song

DOI: https://doi.org/10.7150/jca.93299

IF: 3.9

2024-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.35041.].

oncology
Correction to: EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis

Renjie Wang,Sai Zhang,Xuyi Chen,Nan Li,Jianwei Li,Ruichao Jia,Yuanqing Pan,Haiqian Liang

DOI: https://doi.org/10.1186/s12943-020-01271-w

IF: 37.3

2020-10-30

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction to: Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer

Senlin Zhao,Yushuai Mi,Bingjie Guan,Binbin Zheng,Ping Wei,Yanzi Gu,Zhengxiang Zhang,Sanjun Cai,Ye Xu,Xinxiang Li,Xuefeng He,Xinyang Zhong,Guichao Li,Zhiyu Chen,Dawei Li

DOI: https://doi.org/10.1186/s13045-021-01042-0

2021-02-23

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,hematology
Publisher Correction: Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma

Li-Na You,Qin-Wen Tai,Lin Xu,Yi Hao,Wen-Jia Guo,Qiao Zhang,Qing Tong,Heng Zhang,Wu-Kui Huang

DOI: https://doi.org/10.1038/s41417-021-00338-0

IF: 5.854

2021-04-19

Cancer Gene Therapy

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41417-021-00338-0

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Erratum: The lncRNA HOXA11-AS Regulates Rab3D Expression by Sponging miR-125a-5p Promoting Metastasis of Osteosarcoma [Corrigendum]

DOI: https://doi.org/10.2147/CMAR.S353233

2021-12-23

Abstract:[This corrects the article DOI: 10.2147/CMAR.S196025.].
Correction: SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer

Yaru Tian,Ranran Ma,Yujing Sun,Haiting Liu,Hui Zhang,Yiyuan Sun,Lei Liu,Yuhong Li,Lin Song,Peng Gao

DOI: https://doi.org/10.1038/s41388-020-1377-2

IF: 8.756

2020-09-10

Oncogene

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Erratum: MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer: Erratum.

Yuan Hu,An-Yue Wu,Cong Xu,Ke-Qi Song,Wen-Jing Wang,Xia Yin,Wen Di,Zu-Bei Hong,Li-Hua Qiu

DOI: https://doi.org/10.7150/jca.92673

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.27748.].
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Fei Teng,Ju-Xiang Zhang,Qi-Meng Chang,Xu-Bo Wu,Wei-Guo Tang,Jian-Fa Wang,Jin-Feng Feng,Zi-Ping Zhang,Zhi-Qiu Hu

DOI: https://doi.org/10.1186/s13046-020-01780-y

2020-12-01

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

Zitong Zhao,Lin Li,Peina Du,Liying Ma,Weimin Zhang,Leilei Zheng,Bo Lan,Bailin Zhang,Fei Ma,Bo Xu,Qimin Zhan,Yongmei Song

DOI: https://doi.org/10.7150/thno.82636

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30701.].

medicine, research & experimental
Correction to: DC-SIGN–LEF1/TCF1–miR-185 feedback loop promotes colorectal cancer invasion and metastasis

Menglang Yuan,Xinsheng Zhang,Jingbo Zhang,Keyong Wang,Yu Zhang,Wei Shang,Yinan Zhang,Jingyi Cui,Xiaomeng Shi,Heya Na,Deyu Fang,Yunfei Zuo,Shuangyi Ren

DOI: https://doi.org/10.1038/s41418-021-00736-9

IF: 12.067

2021-03-04

Cell Death and Differentiation

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41418-021-00736-9

cell biology,biochemistry & molecular biology

Correction to: microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.

Microrna-124 Inhibits Bone Metastasis Of Breast Cancer By Repressing Interleukin-11 (Vol 17, 9, 2018)

microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Correction to: Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway

Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17

Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5

Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2

Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Correction: circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer

CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis: Erratum

Correction to: EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis

Correction to: Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer

Publisher Correction: Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma

Erratum: The lncRNA HOXA11-AS Regulates Rab3D Expression by Sponging miR-125a-5p Promoting Metastasis of Osteosarcoma [Corrigendum]

Correction: SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer

Erratum: MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer: Erratum.

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

Correction to: DC-SIGN–LEF1/TCF1–miR-185 feedback loop promotes colorectal cancer invasion and metastasis